We are 204,601 members in 81 forums discussing 148,296 topics.

Help with Abbreviations

All TopicsForum: Clinical Trials, Research News, Podcasts, Study Results → Topic: Breaking Research News from Breastcancer.org

Topic: Breaking Research News from Breastcancer.org

Forum: Clinical Trials, Research News, Podcasts, Study Results —

Share your research articles, interpretations and experiences here. Let us know how these studies affect you and your decisions.

Posted on: Apr 16, 2012 12:33PM - edited Jan 16, 2016 02:28PM by Moderators

Moderators wrote:

Breastcancer.org strives to bring you updates on the latest breast cancer research through its Research News program. Medical experts at Breastcancer.org provide easy-to-understand summaries of what the research means for YOU.

Check out this thread on a regular basis to see all the breaking news about current breast cancer research from our experts.

Get Personalized Research News Stories JUST for You!
Don't forget to fill out your profile: In the top right hand corner of the screen, under My Profile, you'll find My Diagnoses and My Treatments. Once you've provided enough information, we'll send recommended articles. Members can save these articles for later, or archive them when they're finished with them.

If you would like to receive Personalized Research News articles, based on diagnosis and treatment information, you'll need to go into "My Profile" and under the "Recommended Articles", click "turn on".

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Page 29 of 29 (858 results)

Posts 841 - 858 (858 total)

Log in to post a reply

Jan 18, 2018 02:45PM Moderators wrote:

Combo of Tykerb, Herceptin, and Aromatase Inhibitor Seems Best for Metastatic, HER2-Positive, Hormone-Receptor-Positive Disease
January 12, 2018

The combination of Tykerb, Herceptin, and an aromatase inhibitor seems better than just Herceptin and an aromatase inhibitor or just Tykerb and an aromatase inhibitor for treating metastatic HER2-positive, hormone-receptor-positive breast cancer in postmenopausal women. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Jan 18, 2018 02:46PM Moderators wrote:

Lynparza Approved to Treat Metastatic HER2-Negative Breast Cancer in Women With BRCA Mutations
January 12, 2018

On Jan. 12, 2018, the FDA approved Lynparza to treat metastatic HER2-negative breast cancer in women with a BRCA1 or BRCA2 mutation. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Jan 18, 2018 02:47PM Moderators wrote:

Study Estimates Risk of Rare Cancer From Breast Implants
January 16, 2018

A Dutch study estimates that for every 7,000 women who get breast implants, one woman will develop anaplastic large-cell lymphoma in the breast by age 75. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Jan 18, 2018 03:38PM - edited Jan 18, 2018 03:39PM by seagan

Have we heard anything about whether MBCers with other, “BRCA-like" (DNA repair gene) mutations - such as CHEK2, which I have - will be eligible for Lynparza, if not now, soon?

I know of at least one clinical trial looking at another PARP inhibitor in non-BRCA, inherited mutations (a talazoparib trial at Stanford: https://clinicaltrials.gov/ct2/show/NCT02401347 - see cohort arm 2). But that's only at one location and requires measurable disease.

Would love to hear PARP inhibitors are becoming more accessible to those of us with non-BRCA mutations, either through trials or exceptions to narrowly approved drugs like this one.

CHEK2 mutation Dx 2/17/2009, IDC, 1cm, Stage I, Grade 2, 0/3 nodes, ER+/PR+, HER2- Dx 5/20/2016, IDC, Stage IV, metastasized to bone/other, ER+/PR+, HER2- Targeted Therapy 6/1/2016 Ibrance (palbociclib) Hormonal Therapy 6/1/2016 Faslodex (fulvestrant) Chemotherapy 1/26/2017 Xeloda (capecitabine) Radiation Therapy 4/24/2017 External: Bone Radiation Therapy 7/25/2017 External: Bone Hormonal Therapy 10/20/2017 Femara (letrozole) Targeted Therapy 10/20/2017 Afinitor (everolimus) Radiation Therapy 11/9/2017 External: Bone Chemotherapy 1/9/2018 Abraxane (albumin-bound or nab-paclitaxel)
Log in to post a reply

Jan 24, 2018 10:16AM Moderators wrote:

Hi Seagan, and thanks for posting. This thread is reserved for posting only Research News articles provided by Breastcancer.org, in an effort to get the breaking news to the Community, without diverting the conversation to other discussions about specific stories. If you'd like to further discuss an article here, we'd suggest going to the specific thread on this article: community.breastcancer.org/for... or starting your own thread here in the Research News forum.

Thank you for understanding!

--The Mods

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Jan 24, 2018 10:17AM Moderators wrote:

Study Estimates Risks of Radiation Treatment for Breast Cancer in Women With Scleroderma
January 19, 2018

Research suggests that some women diagnosed with scleroderma and breast cancer treated with radiation had long-term skin tightening or thickening in the treatment area, but no disease flare-up. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Jan 26, 2018 01:19PM Moderators wrote:

Two New Genetic Mutations Linked to Higher Risk of Breast Cancer
January 24, 2018

A study has found that mutations in the MSH6 and PMS2 genes are linked to higher-than-average breast cancer risk. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Feb 1, 2018 01:34PM Moderators wrote:

Exercise Boosts Health of Breast Cancer Survivors
January 30, 2018

Regular exercise may increase the life expectancy of breast cancer survivors by lowering survivors' increased risk of heart disease and type 2 diabetes, along with recurrence. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Feb 1, 2018 04:04PM Moderators wrote:

Program Can Help Ease Body Image Concerns and Improve Quality of Life
February 1, 2018

The Restoring Body Image After Cancer group therapy program, which uses guided imagery, seems to help improve body image as well as quality of life in women treated for breast cancer. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Feb 2, 2018 04:33PM Moderators wrote:

Yet Another Biosimilar Seems as Safe and as Effective as Herceptin
February 2, 2018

SB3, a biosimilar to Herceptin, seems as effective and as safe as Herceptin. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Feb 13, 2018 01:15PM Moderators wrote:

ASCO Releases Guidelines on Ways to Treat Sexual Problems in People With Cancer
February 9, 2018

The American Society of Clinical Oncology has issued new guidelines on ways doctors can help treat sexual problems in people diagnosed with cancer. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Feb 23, 2018 04:35PM Moderators wrote:

Study Compares Four Genomic Tests for Breast Cancer
February 20, 2018

A study compared four genomic tests used to analyze early-stage, hormone-receptor-positive, HER2-negative breast cancer, but it's important to know the difference between prognostic and predictive tests when interpreting the results. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Mar 9, 2018 12:44PM Moderators wrote:

FDA Authorizes 23andMe BRCA Genetic Test, but Test Only IDs Three Mutations
March 7, 2018

The FDA has authorized a direct-to-consumer test to identify BRCA mutations, but it's important to know that the test only looks for three mutations that are extremely rare in the general population. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Mar 20, 2018 12:28PM Moderators wrote:

Most Newly Diagnosed Women Don't Receive Genetic Counseling, Even Though They Should Have It
March 16, 2018

Fewer than 50% of women newly diagnosed with breast cancer who should receive advice from a licensed genetic counselor actually get counseling. In addition, only about half of the women who should have genetic testing actually have that testing. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Mar 20, 2018 12:28PM Moderators wrote:

New Guidelines Say Accelerated Whole-Breast Irradiation Should Be Used to Treat Most Breast Cancers
March 18, 2018
The updated guidelines say that most women diagnosed with breast cancer should be treated with accelerated whole-breast irradiation as the standard of care. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Mar 23, 2018 04:46PM Moderators wrote:

Researchers Identify 110 Genes Associated With Breast Cancer
March 21, 2018

A research team has associated 110 genes with a higher risk of breast cancer using a new genetic analysis technique. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Apr 5, 2018 12:13PM - edited Apr 5, 2018 12:16PM by Moderators

Scalp Cooling Is Safe, Effective for Reducing Hair Loss Due to Chemotherapy, Study Finds
March 30, 2018

A retrospective study found that scalp cooling was effective and that the risk of scalp skin metastases was extremely low and should not interfere with the use of scalp cooling. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Apr 16, 2018 08:09AM swimjames wrote:

This Post has been removed by the Community.

Page 29 of 29 (858 results)